Laurs & Bridz Pharmaceuticals Private Limited, a active private limited company, was established on 20 April 2011 in Ghaziabad, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233UP2011PTC044425. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.40 M.
Formerly known as Laurs & Bridz Salesmart Private Limited. It upholds a compliant status. Its leadership includes Manu Chaudhary (Director), Shubha Goel (Additional Director). Past directors included Rekha Rani, Devendra Singh, Rekha Goel. It holds ₹0.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H. No. 183 New Arya Nagar, Delhi-Meerut Road, Ghaziabad, Uttar Pradesh, 201001.
U24233UP2011PTC044425
044425
20 April 2011
₹1.00 M
₹0.40 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Laurs & Bridz Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manu Chaudhary | Director | 11 Nov 2021 | Current |
| Shubha Goel | Additional Director | 02 Dec 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Feb 2013 | Past |
| Pramod Abcsdd | Director | 11 Nov 2021 | Past |
| Pramod Abcsdd | Director | 06 Dec 2019 | Past |
| Pramod Abcsdd | Director | 15 Nov 2024 | Past |
| Pramod Abcsdd | Director | 11 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Laurs & Bridz Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 46.06% decrease. The company also saw a substantial fall in profitability, with a 39.88% decrease in profit. The company's net worth moved up by a moderate rise of 2.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Laurs & Bridz Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 2017 | Syndicate Bank | ₹0.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Laurs & Bridz Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Laurs & Bridz Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laurs & Bridz Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Laurs & Bridz Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Laurs & Bridz Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
The activity Manu Chaudhary was appointed as a Director was appointed as a Director on 11 Nov 2021 & has been associated with this company since 4 years 13 days . was completed.
The activity Shubha Goel was appointed as a Additional Director was appointed as a Additional Director on 02 Dec 2019 & has been associated with this company since 5 years 11 months . was completed.
Progress on A charge with Syndicate Bank amounted to Rs. 0.50 M with Charge ID 100098450 was registered on 26 Apr 2017. was documented.
Progress on Laurs & Bridz Pharmaceuticals Private Limited was registered on 20 Apr 2011 with Roc Kanpur & aged 14 years 7 months as per MCA records. was documented.
The CIN of Laurs & Bridz Pharmaceuticals Private Limited is U24233UP2011PTC044425.
Laurs & Bridz Pharmaceuticals Private Limited is headquartered at H. No. 183 New Arya Nagar, Delhi-Meerut Road, Ghaziabad, Uttar Pradesh, 201001.
Laurs & Bridz Pharmaceuticals Private Limited was incorporated on 20 April 2011.
The current directors of Laurs & Bridz Pharmaceuticals Private Limited are
The primary industry of Laurs & Bridz Pharmaceuticals Private Limited is Trade.
Laurs & Bridz Pharmaceuticals Private Limited is unlisted.
The authorized capital of Laurs & Bridz Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.40 M.
The compliance status of Laurs & Bridz Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX